Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R V Giles

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nucleic Acids Research|March 25, 1995
Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cellsR V Giles, C J Ruddell, D G Spiller, et al.
Nucleic Acids Research|May 30, 1998
Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cellsR V Giles, D G Spiller, J Grzybowski, et al.
Nucleic Acids Research|August 28, 2001
Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNAB H Lloyd, R V Giles, D G Spiller, et al.
Blood|August 29, 2000
Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cellsD A Moulding, R V Giles, D G Spiller, et al.
Nucleic Acids Research|June 28, 2000
Oligodeoxynucleotide 5mers containing a 5'-CpG induce apoptosis through a mitochondrial mechanism in T lymphocytic leukaemia cellsD M Tidd, D G Spiller, C M Broughton, et al.
Antisense & Nucleic Acid Drug Development|September 22, 1998
The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responsesD G Spiller, R V Giles, C M Broughton, et al.
Leukemia|September 26, 1997
Preclinical studies of streptolysin-O in enhancing antisense oligonucleotide uptake in harvests from chronic myeloid leukaemia patientsC M Broughton, D G Spiller, N Pender, et al.
Bone Marrow Transplantation|July 22, 1999
Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemiaR E Clark, J Grzybowski, C M Broughton, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nucleic Acids Research|March 25, 1995
Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cellsR V Giles, C J Ruddell, D G Spiller, et al.
Nucleic Acids Research|May 30, 1998
Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cellsR V Giles, D G Spiller, J Grzybowski, et al.
Nucleic Acids Research|August 28, 2001
Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNAB H Lloyd, R V Giles, D G Spiller, et al.
Blood|August 29, 2000
Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cellsD A Moulding, R V Giles, D G Spiller, et al.
Nucleic Acids Research|June 28, 2000
Oligodeoxynucleotide 5mers containing a 5'-CpG induce apoptosis through a mitochondrial mechanism in T lymphocytic leukaemia cellsD M Tidd, D G Spiller, C M Broughton, et al.
Antisense & Nucleic Acid Drug Development|September 22, 1998
The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responsesD G Spiller, R V Giles, C M Broughton, et al.
Leukemia|September 26, 1997
Preclinical studies of streptolysin-O in enhancing antisense oligonucleotide uptake in harvests from chronic myeloid leukaemia patientsC M Broughton, D G Spiller, N Pender, et al.
Bone Marrow Transplantation|July 22, 1999
Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemiaR E Clark, J Grzybowski, C M Broughton, et al.
Pageof 2